It is a financial services private limited company based in Mumbai, Maharashtra, India, established in 1981.
1981 | Mumbai, Maharashtra, India | ActivePadma Pharmaceuticals Private Limited, a active private limited company, was established on 21 January 1981 in Mumbai, Maharashtra, India. Engaging in financial holding companies within the manufacturing sector, it holds CIN: U24200MH1981PTC023725. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹9.14 Cr.
It upholds a compliant status. Its leadership includes Rajiv Shrigopal Bajaj (Director), Shrigopal Rangnath Bajaj (Director). Past directors included Ravish Govind Murarka. It holds ₹17.75 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 2Nd Floor, Plot No. 48, Service Road, Western Express Highway, Vile Parle (Eas, T), Mumbai, Maharashtra, 400057.
U24200MH1981PTC023725
023725
21 January 1981
₹10.00 Cr
₹9.14 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Padma Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajiv Shrigopal Bajaj | Director | 22 Dec 1983 | Current |
| Shrigopal Rangnath Bajaj | Director | 21 Jan 1981 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 Dec 2008 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Padma Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 43.6% increase. The company also saw a substantial improvement in profitability, with a 64.88% increase in profit. The company's net worth moved up by a moderate rise of 2.16%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Padma Pharmaceuticals had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹177,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Feb 2019 | Others | ₹6.75 Cr | Open |
| 28 May 2015 | Bajaj Finance Limited | ₹11.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Padma Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Padma Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Padma Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Padma Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Padma Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
A charge with Others amounted to Rs. 6.75 Cr with Charge ID 100248735 was registered on 28 Feb 2019. was recorded as a recent event.
The activity A charge with Bajaj Finance Limited amounted to Rs. 11.00 Cr with Charge ID 10571122 was registered on 28 May 2015. was completed.
Rajiv Shrigopal Bajaj was appointed as a Director was appointed as a Director on 22 Dec 1983 & has been associated with this company since 42 years 22 days . was recorded as a recent event.
Progress on Shrigopal Rangnath Bajaj was appointed as a Director was appointed as a Director on 21 Jan 1981 & has been associated with this company since 44 years 11 months . was documented.
The CIN of Padma Pharmaceuticals Private Limited is U24200MH1981PTC023725.
Padma Pharmaceuticals Private Limited is headquartered at 2Nd Floor, Plot No. 48, Service Road, Western Express Highway, Vile Parle (Eas, T), Mumbai, Maharashtra, 400057.
Padma Pharmaceuticals Private Limited was incorporated on 21 January 1981.
The current directors of Padma Pharmaceuticals Private Limited are
The primary industry of Padma Pharmaceuticals Private Limited is Manufacturing.
Padma Pharmaceuticals Private Limited is unlisted.
The authorized capital of Padma Pharmaceuticals Private Limited is ₹10.00 Cr, and the paid-up capital is ₹9.14 Cr.
The compliance status of Padma Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX